date,action,name,rate,target
Oct-23-18,Upgrade,Imperial Capital,Underperform to In-line,$25 to $29
Nov-05-18,Downgrade,UBS,Buy to Neutral,
Nov-29-18,Resumed,Goldman,Neutral,$34
Jan-02-19,Upgrade,Barrington Research,Mkt Perform to Outperform,$35
Jan-11-19,Upgrade,Imperial Capital,In-line to Outperform,$37
Jan-15-19,Upgrade,Pivotal Research Group,Hold to Buy,$33 to $36
